Search

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.

… Monday, December 15, 2025 The U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role.  These approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types 

Memorial Sloan Kettering Cancer Center (MSK) was recently notified of a data security incident by Blackbaud, a third-party vendor and provider of fundraising software used by MSK’s Office of Development. This incident at Blackbaud affected hundreds of nonprofits and higher education institutions around the world, including MSK.

… Monday, September 14, 2020 Memorial Sloan Kettering Cancer Center (MSK) was recently notified of a data security incident by Blackbaud, a third-party vendor and provider of fundraising software used by MSK’s Office of Development. This incident at Blackbaud affected hundreds of nonprofits and higher

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.

… Wednesday, April 22, 2026 Dozens of clinicians and scientists from across Memorial Sloan Kettering Cancer Center (MSK) presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting , held April 17 to 22 in San Diego.  MSK’s presence spanned

Learn about Dana and the uterine transposition surgery at MSK in NYC, that enabled her to give birth to a baby named Hudson, who made history.

… Tuesday, September 3, 2024 When Dana Vergara cradles her sweet baby, Hudson, she can hardly believe it.  Dana was 33 years old and the mother of a 5-month-old daughter, Jolene, when she learned that she had  stage 3 rectal cancer . She knew it was bad. She wasted no time reaching out to specialists at

Conozca a Dana y la cirugía de transposición uterina en MSK en la ciudad de Nueva York, que le permitió dar a luz a un bebé llamado Hudson, que hizo historia.

… Tuesday, September 3, 2024 Cuando Dana Vergara acuna a su dulce bebé, Hudson, apenas puede creerlo.  Dana tenía 33 años y era madre de una hija de 5 meses, Jolene, cuando se enteró de que tenía cáncer de recto en estadio 3 . Sabía que era malo. No demoró en ponerse en contacto con los especialistas del

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.

… Thursday, July 25, 2024 Imagine finding out that your bone marrow or blood stem cells could save the life of someone who needed it — even a complete stranger. Memorial Sloan Kettering Cancer Center (MSK) nurse Grace Yang, RN, received such a call in March 2024.   “This is definitely something I was never

MSK's Neil Iyengar will present at the American Association for Cancer Research special conference about the risk of invasive breast cancer. A new study found that the risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat. These findings suggest that having a normal BMI can provide false reassurance regarding the risk of breast cancer associated with body fat, and they also highlight the potential role of physical activity and exercise even in those who are at a normal weight. For expert interviews, please contact Nicole H. McNamara at [email protected].

… Friday, January 26, 2018 Bottom Line: The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer. In addition, a lower level of

Dr. Sawyers is recognized for his dedication to cancer research, education, collaboration, science policy, advocacy, and funding.

… Friday, April 9, 2021 Memorial Sloan Kettering (MSK) is proud to announce that Charles L. Sawyers, MD, FAACR , Chair of MSK’s Human Oncology and Pathogenesis Program (HOPP) and Howard Hughes Medical Institute Investigator, will receive the 2021 American Association for Cancer Research (AACR) Distinguished

Memorial Sloan Kettering Cancer Center announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient medical facility to be known as The David H. Koch Center for Cancer Care. The new center will provide the most advanced cancer treatments in a dynamic space designed with the needs of patients firmly in mind.

… Wednesday, May 20, 2015 Memorial Sloan Kettering Cancer Center (MSK) today announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient

During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.

… Friday, May 15, 2020 Summary During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments. As leaders in immunotherapy, Memorial Sloan Kettering researchers have spent decades studying how the immune system responds to cancer